Author

K. Boonnak

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Immunogenicity and safety of high-dose versus double-dose quadrivalent inactivated influenza vaccine in adult kidney transplant recipients: a randomized controlled trial (2023)

Summary Background Solid organ transplant (SOT) recipients are at increased risk of influenza-related complications and often exhibit suboptimal vaccine responses. While both high-dose (HD) and double-dose (DD) quadrivalent inactivated influenza vaccines (QIIV) aim to enhance immunogenicity compared to the standard dos...

Thanachote Arayanumas, K. Boonnak, S. Kantachuvesiri et al. · The Lancet Regional Health -... · 0 citations

#protein folding Open access Oct 2026

Phosphoprotein-enriched proteomics identifies heat shock cognate 71 protein as a host factor supporting chikungunya virus replication in macrophages

The Chikungunya virus (CHIKV) infection induces an acute illness and ongoing inflammatory symptoms, with macrophages believed to play significant yet not fully understood roles. To characterize host cellular responses associated with CHIKV infection, we performed mass spectrometry–based phosphoprotein enrichment-ba...

Nattaya Kamchompoo, Songkran Thongon, Artittaya Athipanyasilp et al. · Scientific Reports · 0 citations

Open access Sep 2026

Immunogenicity and safety of high-dose versus standard-dose quadrivalent inactivated influenza vaccine in patients living with HIV: a randomized controlled trial.

It is suggested that HD IIV4 may enhance immunogenicity in PLWH and warrant further investigation in studies evaluating clinical effectiveness, as well as increasing the risk of adverse events compared to SD IIV4.

Nutchaya Laoharattanahirun, S. Kiertiburanakul, K. Boonnak et al. · Vaccine · 0 citations